In a striking contrast of fortunes in the Exchange-Traded Fund (ETF) market on Friday, the Uranium ETF outperformed its peers, while the ARK Genomic Revolution ETF struggled.
The Uranium ETF reported a significant rise of approximately 3.9%, primarily driven by the robust performance of certain components of the fund. Specifically, UR Energy and Uranium Energy (NYSE:UEC) both appreciated by about 6.5%. This surge marked a noteworthy development in the ETF market.
On the other hand, the ARK Genomic Revolution ETF didn't fare as well on the same day, recording a decline of around 7.4%. Certain components of this ETF contributed to its weaker performance. Shares of Exact Sciences (NASDAQ:EXAS) and Intellia Therapeutics (NASDAQ:NTLA) fell by approximately 1.9% and 1.8% respectively.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.